Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
... patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death ... Read More
-
Home Healthcare Market, By Product & Services (Product (Diagnostics and Monitoring Home Devices, Therapeutics Home Healthcare Devices, Mobility Assist Devices, Medical Supplies) and Services (Rehabilitation Services, Telehealth and Telemedicine Services, Infusion Therapy Services, Respiratory Therapy Services, Unskilled Home Healthcare Services)), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders, Neurological & Mental Disorders, Respiratory Disease & COPD, Maternal Disorders, Mobility Disorders, Cancer, Wound Care, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... and services. Home healthcare provides medical care and services to patients at their home for illnesses or injuries that otherwise may require hospitalization or care at nursing home. It allows patients to receive medical treatment ... Read More
-
Blood Flow Measurement Devices Market, By Product Type (Laser Doppler Blood Flowmeters, Ultrasonic Doppler Blood Flowmeters, and Electromagnetic Blood Flowmeters), By Application (Cardiovascular Disease, Tumor Monitoring, Gastroenterology, Diabetes, Dermatology, and Others), By End User (Hospital, Clinics, Ambulatory Surgical Centers, Specialty Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... heart failure, coronary artery disease etc has boosted demand for advanced blood flow measurement devices that helps achieve accurate diagnosis. Constant technological advancements in medical devices industry has led to development of non-invasive and minimally-invasive ... Read More
-
Allulose Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... expansion as consumers increasingly prioritize healthier choices without sacrificing taste. Allulose, a rare sugar with minimal caloric content, is gaining traction among individuals seeking sugar alternatives, particularly those managing diabetes or maintaining low-calorie diets. The ... Read More
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
... age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role ... Read More
-
U.S. Sterile Injectables Market, By Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, and Others), By Therapeutic Application (Cancer, Metabolic Disorder, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... that are administered via various injection routes such as intravenous, intramuscular, subcutaneous, and others in their final sterile form for healing or preventing medical conditions. The rising prevalence of chronic diseases like cancer, diabetes, autoimmune ... Read More
-
U.S. Home Infusion Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... cases of hospital-acquired infections, and a growing aging population are key drivers behind this expansion. Home infusion therapy allows patients to receive medications intravenously or through non-oral routes within their homes. This method is used ... Read More
-
Global Type 2 Diabetes Market 2025-2029
... 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis - United States - 2025-2031 - MedSuite - Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more
... market segments, including: Blood Glucose Meters, Blood Glucose Test Strips, Lancets Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM) Insulin & GLP-1 Receptor Agonists (e.g., Ozempic®) Insulin Pens, Insulin Syringes, and Insulin Pumps Key ... Read More
-
Medical Foods Global Market Report 2025 Including: 1) By Type: Pills; Powder 2) By Application: Alzheimer's Disease; Diabetic Neuropathy; Nutritional Deficiency; ADHD 3) By Sales Channel: Retail Sales; Online Sales; Institutional Sales Covering: Nestlé SA; Danone SA; Fresenius Kabi AG; Mead Johnson & Company LLC; Primus Pharmaceuticals Inc.
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
North America Hemodynamic Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... The COVID-19 pandemic significantly impacted the North American hemodynamic monitoring market. Patients with COVID-19 respiratory failure showed a marked rise in blood pressure over time, not accompanied by distinctive markers of circulatory failure. For instance, ... Read More
-
Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
... rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, ... Read More
-
Rare Endocrine Disease Treatment
... 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Acromegaly Indication, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.7 Billion by the ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring Systems, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2024-2030. Digital Diabetes Devices, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$46.7 Billion by the end ... Read More
-
Human Insulin
... CAGR of 6.8% over the analysis period 2024-2030. HI Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$70.6 Billion by the end of the analysis ... Read More
-
Insulin Patch Pumps
... at a CAGR of 9.8% over the analysis period 2024-2030. Basal & Bolus Delivery, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$1.4 Billion by the ... Read More
-
Diabetic Foot Ulcers and Pressure Ulcers
... reach US$6.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Diabetic Foot Ulcers, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and ... Read More
-
Insulin Pen Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution Form, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Diabetes Injection Pens
... at a CAGR of 5.7% over the analysis period 2024-2030. Insulin Pens, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$8.2 Billion by the end of ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
Research Assistance
